Every GeneLens report is built on published genetics research, independently reviewed, and updated when the evidence changes.
Our partner laboratory holds Clinical Laboratory Improvement Amendments (CLIA) certification - the federal standard for high-complexity genetic testing in the United States.
Your genetic data is treated as protected health information under HIPAA. We implement encryption at rest and in transit, with strict access controls and audit logging.
All health and pharmacogenomics reports cite the primary literature used to establish each association. You can review the studies that back your results.
GeneLens uses high-density SNP microarray genotyping to analyze over 700,000 positions in your genome. This method has been the industry standard for consumer genetics for over a decade - well-characterized, reproducible, and highly accurate.
Your raw sample undergoes extraction, amplification, hybridization, and scanning before the data reaches our interpretation pipeline. Each step includes quality control checkpoints. Samples that don't meet our minimum call rate threshold are flagged for re-extraction.
Raw genotype data doesn't mean much without rigorous interpretation. Our algorithms compare your variants against curated databases - including ClinVar, GWAS Catalog, and PharmGKB - to generate your reports.
For ancestry analysis, we use a reference population panel spanning over 200 groups worldwide, built from public and licensed datasets. Admixture estimates are computed using validated population genetics methods.
We don't sell your genetic data. We don't share it with insurers, employers, or third-party advertisers. Period. Your genome is de-identified in storage and linked to your account only through a secure identifier.
You can delete your data at any time from your portal settings. Deletion is complete - raw sample, processed genotype data, and reports. We retain only the minimum records required for legal compliance for 30 days following deletion requests.